MedPath

Feasibility and Psychometric Properties of Paper vs. Web vs. Automated Telephone Administration of Patient Reported Outcome Surveys

Completed
Conditions
Colon Cancer
Rectal Cancer
Interventions
Behavioral: Surveys
Registration Number
NCT01458509
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

It can be difficult to obtain the perspective of patients who have had bowel surgery. This study is being done because the investigators are trying to find out whether patient-reported outcomes, (results reported to investigators by the patient), on a regular basis, will help the investigators provide better patient care and symptom management.

Therefore, the purpose of this study is to determine if it is possible and if it is useful to their medical care for patients who have had bowel surgery to complete surveys about their symptoms on a regular basis. In this study the surveys are completed from home, by web or by telephone, every month for 6 months. The results of this study will guide the design of large research studies on cancer-related bowel function.

The purpose of this study is to develop a bowel function questionnaire for patients with colorectal cancer. The questionnaire will be used in future clinical trials to assess bowel function.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
325
Inclusion Criteria

Aim 1:

  • Stage I-III rectal cancer
  • Post sphincter preserving surgery with restoration of bowel continuity within last 4-6 weeks at MSKCC.
  • Access to web and email from home
  • Web avidity (≥2 uses of email/week)
  • Able to read and write in English
  • Age ≥ 18

Aim 2:

  • Stage I-III colon and rectal cancer
  • Post surgical resection of primary tumor at MSKCC
  • Access to web and email from home
  • Web avidity (≥2 uses of email/week)
  • Able to read and write in English
  • Age ≥ 18
Read More
Exclusion Criteria

Aim 1:

  • Metastatic disease - Auditory, visual or motor impairment that would preclude ability to use telephone and/or computer.
  • Stoma
  • Participated in Aim 2
  • Definitive SPS = Transanal Excision (TAE) or Transanal Endoscopic Microsurgery (TEM)

Aim 2:

  • Metastatic disease - Auditory, visual or motor impairment that would preclude ability to use telephone and/or computer.
  • Stoma
  • Participated in Aim 1
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Web EASPSurveysWeb Group with Nurse Intervention
IVRS ( interactive voice response system) No EASPSurveysTelephone Group without nurse intervention
IVRS ( interactive voice response system) EASPSurveysTelephone Group with Nurse Intervention
Web No EASPSurveysWeb Group without nurse intervention
Primary Outcome Measures
NameTimeMethod
feasibility of electronic PRO assessment2 years

we define feasibility as being the completion of 4/6 surveys. A complete survey is defined as having responses to 17/24 items (70%) on the survey. The administration mode will be deemed feasible if \>=70% of patients complete 4/6 surveys.

clinically useful to collect patient-reported data6 months

using electronic methods (interactive voice response system (IVRS) or web interface)

Secondary Outcome Measures
NameTimeMethod
psychometric equivalence2 years

Relevant in colorectal cancer trials via three different modes of administration: Web, IVRS, paper. The primary interest is the psychometric properties of the total score and subscale scores of the BFI, however individual items scores will be examined as well.

problems people experience2 years

With bowel function, bladder function, and sexual function over the course of treatment for rectal cancer and to identify the types of information that would be helpful to future patients. Patients who were enrolled in Aim 1 will be asked to participate in a 30-45 minute telephone interview. A total of 20 interviews will be conducted.

Trial Locations

Locations (1)

Memorial Sloan-Kettering Cancer Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath